Versant Venture Management as of Sept. 30, 2018
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 10 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Crispr Therapeutics (CRSP) | 54.4 | $160M | 3.6M | 44.35 | |
| Audentes Therapeutics | 16.2 | $48M | 1.2M | 39.59 | |
| Veracyte (VCYT) | 11.8 | $35M | 3.6M | 9.55 | |
| Ocular Therapeutix (OCUL) | 5.2 | $15M | 2.2M | 6.88 | |
| Cymabay Therapeutics | 4.1 | $12M | 1.1M | 11.08 | |
| Second Sight Med Prods | 2.9 | $8.5M | 4.5M | 1.90 | |
| Immune Design | 2.6 | $7.6M | 2.2M | 3.45 | |
| Achaogen | 1.7 | $5.1M | 1.3M | 3.99 | |
| Clovis Oncology | 1.0 | $3.0M | 102k | 29.37 | |
| Opgen | 0.1 | $207k | 102k | 2.03 |
